Home - Products - Others - Other Targets - 2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone

2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone

CAS No. 1622982-60-8

2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone( ——— )

Catalog No. M38248 CAS No. 1622982-60-8

2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	Get Quote	Get Quote
50MG	Get Quote	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone
Note

Research use only, not for human use.
Brief Description

2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone
Description

2-O-β-D-Glucopyranosyloxy-1,7,8-trimethoxy-3-methylanthraquinone
In Vitro

———
In Vivo

———
Synonyms

———
Pathway

Others
Target

Other Targets
Recptor

———
Research Area

———
Indication

———

Chemical Information

CAS Number

1622982-60-8
Formula Weight

———
Molecular Formula

———
Purity

>98% (HPLC)
Solubility

———
SMILES

———
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

MAGE-A3 195-203

This peptide MAGE-3-encoded HLA-A24 epitope is a high MHC binder.The identification of this MAGE-3/HLA-A24 peptide may as a result effectiveially offer the opportunities to design peptide-based immunotherapeutic approaches that might prove to be potent in treating patients with MAGE-3-positive malignant tumors.
Koumine

Koumine has antineoplastic effect, may be a future breast cancer chemotherapeutic agent.
R9-TAT

R9-TAT

Sign In Join Free